In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
✍ Scribed by Ramakers-van Woerden, N L; Beverloo, H B; Veerman, A J P; Camitta, B M; Loonen, A H; van Wering, E R; Slater, R M; Harbott, J; den Boer, M L; Ludwig, W D
- Book ID
- 110055778
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 197 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Infant acute lymphoblastic leukemia (ALL) with __MLL__ gene rearrangements is characterized by a proB phenotype and a poor clinical outcome. We analyzed an infant proB ALL with t(2;11)(p15;p14) and an __MLL__ rearrangement on Southern blot analysis. Rapid amplification of cDNA ends–poly
## Abstract ## Background The t(9;22)(q34;q11) translocation leading to the Philadelphia (Ph) chromosome resulting in __BCR‐ABL__ gene fusion is associated with a poor prognosis in acute lymphoblastic leukemia (ALL). ## Procedure We studied the relation between t(9;22), determined by karyotype,
## Abstract Decreased activity of hypoxanthine‐guanine phosphoribosyltransferase (HGPRT), responsible for the conversion of 6‐mercaptopurine and 6‐thioguanine (6‐TG) to their cytotoxic nucleotides, may cause resistance to these thiopurines in experimental leukemic systems. The clinical significance